Top

Inflammation Research

Published in:

01-10-2018 | Original Research Paper

Evaluation of neuroprotective effects of insulin on immuno-inflammatory and systemic disorders induced by kaliotoxin, a Kv1.3 channel blocker

Authors: Zahida Taibi-Djennah, Marie-France Martin-Eauclaire, Fatima Laraba-Djebari

Published in: Inflammation Research | Issue 10/2018

Abstract

Objective

Kaliotoxin2 (KTX2) is a highly selective blocker of voltage-dependent potassium channels Kv1.3 containing 37 amino acid residues. It is purified from Androctonus australis scorpion venom. The binding of KTX2 to its targets is able to alter the neuronal excitability leading to neurological disorders, accompanied by an inflammatory response. In brain, activation of insulin receptor signaling pathway by insulin induces current suppression and concomitant tyrosine phosphorylation of Kv1.3 channel. The aim of this study is to evaluate the effect of insulin injected by i.c.v. route on the neuro-pathophysiological and systemic disorders induced by KTX2.

Materials and methods

Tissue damage, inflammatory response and oxidative stress biomarkers were assessed in NMRI mice at 24 h after co-injection of KTX2 and insulin by intracerebroventricular route.

Results

Obtained results revealed that the central administration of insulin prevents cerebral cortex injury, brain edema and blood–brain barrier alteration induced by KTX2, these are accompanied by significant decrease of systemic disorders including serum cytokines, inflammatory and oxidative stress markers and tissue damage.

Conclusion

These results indicate that insulin is able to reduce neuro-immunological effects and systemic disorders induced by KTX2. The neuroprotective effect of insulin may be due to its crucial role in the regulation of inflammation response and its properties to modulate the activity of Kv1.3 channels in brain.

Rodriguez de la Vega RC, Possani LD. Current views on scorpion toxins specific for K+-channels. Toxicon. 2004;43(8):865–75. https://doi.org/10.1016/j.toxicon.2004.03.022.CrossRef

Tytgat J, Chandy KG, Garcia ML, Gutman GA, Martin-Eauclaire MF, van der Walt JJ, et al. A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol. Sci. 1999;20(11):444–7.CrossRefPubMed

Tan PT, Veeramani A, Srinivasan KN, Ranganathan S, Brusic V. SCORPION2: a database for structure-function analysis of scorpion toxins. Toxicon. 2006;47(3):356–63. https://doi.org/10.1016/j.toxicon.2005.12.001.CrossRefPubMed

Quintero-Hernandez V, Jimenez-Vargas JM, Gurrola GB, Valdivia HH, Possani LD. Scorpion venom components that affect ion-channels function. Toxicon. 2013;76:328–42. https://doi.org/10.1016/j.toxicon.2013.07.012.CrossRefPubMedPubMedCentral

Ortiz E, Gurrola GB, Schwartz EF, Possani LD. Scorpion venom components as potential candidates for drug development. Toxicon. 2015;93C:125–35. https://doi.org/10.1016/j.toxicon.2014.11.233.CrossRef

Laraba-Djebari F, Legros C, Crest M, Ceard B, Romi R, Mansuelle P, et al. The kaliotoxin family enlarged. Purification, characterization, and precursor nucleotide sequence of KTX2 from Androctonus australis venom. J Biol Chem. 1994;269(52):32835–43.PubMed

Zachariae U, Schneider R, Velisetty P, Lange A, Seeliger D, Wacker SJ, et al. The molecular mechanism of toxin-induced conformational changes in a potassium channel: relation to C-type inactivation. Structure. 2008;16(5):747–54. https://doi.org/10.1016/j.str.2008.01.018.CrossRefPubMed

Ladjel-Mendil A, Martin-Eauclaire MF, Laraba-Djebari F. Neuropathophysiological effect and immuno-inflammatory response induced by kaliotoxin of androctonus scorpion venom. Neuroimmunomodulation. 2013;20(2):99–106. https://doi.org/10.1159/000345706.CrossRefPubMed

Taibi-Djennah Z, Matin-Eauclaire MF, Laraba-Djebari F. Systemic responses following brain injuries and inflammatory process activation induced by a neurotoxin of Androctonus scorpion venom. Neuroimmunomodulation. 2015. https://doi.org/10.1159/000371493.PubMedCrossRef

10.

Sifi N, Martin-Eauclaire MF, Laraba-Djebari F. K(+) channel blocker-induced neuroinflammatory response and neurological disorders: immunomodulatory effects of astaxanthin. Inflamm. Res. 2016;65(8):623–34. https://doi.org/10.1007/s00011-016-0945-y.CrossRefPubMed

11.

Bessone R, Martin-Eauclaire MF, Crest M, Mourre C. Heterogeneous competition of Kv1 channel toxins with kaliotoxin for binding in rat brain: autoradiographic analysis. Neurochem. Int. 2004;45(7):1039–47. https://doi.org/10.1016/j.neuint.2004.05.006.CrossRefPubMed

12.

Mourre C, Chernova MN, Martin-Eauclaire MF, Bessone R, Jacquet G, Gola M, et al. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits. J. Pharmacol. Exp. Ther. 1999;291(3):943–52.PubMed

13.

Ladjel-Mendil A, Martin-Eauclaire MF, Laraba-Djebari F. Neuro-modulation of immuno-endocrine response induced by kaliotoxin of Androctonus scorpion venom. J. Biochem. Mol. Toxicol. 2016;30(12):580–7. https://doi.org/10.1002/jbt.21824.CrossRefPubMed

14.

Lu J, Goh SJ, Tng PY, Deng YY, Ling EA, Moochhala S. Systemic inflammatory response following acute traumatic brain injury. Front Biosci (Landmark Ed). 2009;14:3795–813.CrossRef

15.

Jacome T, Tatum D. Systemic inflammatory response syndrome (SIRS) score independently predicts poor outcome in isolated traumatic brain injury. Neurocrit. Care. 2018;28(1):110–6. https://doi.org/10.1007/s12028-017-0410-y.CrossRefPubMed

16.

Havrankova J, Roth J, Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature. 1978;272(5656):827–9.CrossRefPubMed

17.

Fadool DA, Tucker K, Phillips JJ, Simmen JA. Brain insulin receptor causes activity-dependent current suppression in the olfactory bulb through multiple phosphorylation of Kv1.3. J. Neurophysiol. 2000;83(4):2332–48.CrossRefPubMedPubMedCentral

18.

Werner H, LeRoith D. Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects. Eur. Neuropsychopharmacol. 2014;24(12):1947–53. https://doi.org/10.1016/j.euroneuro.2014.01.020.CrossRefPubMed

19.

Franklin JL, Bennett WL, Messina JL. Insulin attenuates TNFα-induced hemopexin mRNA: an anti-inflammatory action of insulin in rat H4IIE hepatoma cells. Biochem. Biophys. Rep. 2017;9:211–216PubMedPubMedCentral

20.

Andreelli F, Jacquier D, Keufer F. Propriétés anti-inflammatoires de l’insuline chez les patients en réanimation. Réanimation. 2006;15(6):467–73.CrossRef

21.

Devos P. Effets propres de l’insuline par rapport au contrôle glycémique. Réanimation. 2008;17:8–11.CrossRef

22.

Bougle A, Annane D. Effect of insulin: from the cell to the total body. Ann. Fr. Anesth. Reanim. 2009;28(5):e193-9. https://doi.org/10.1016/j.annfar.2009.02.029.CrossRefPubMed

23.

Deng HP, Chai JK. The effects and mechanisms of insulin on systemic inflammatory response and immune cells in severe trauma, burn injury, and sepsis. Int. Immunopharmacol. 2009;9(11):1251–9. https://doi.org/10.1016/j.intimp.2009.07.009.CrossRefPubMed

24.

Rosas-Hernandez H, Ramirez M, Ramirez-Lee MA, Ali SF, Gonzalez C. Inhibition of prolactin with bromocriptine for 28 days increases blood–brain barrier permeability in the rat. Neuroscience. 2015;301:61–70. https://doi.org/10.1016/j.neuroscience.2015.05.066.CrossRefPubMed

25.

Tao X, Chen X, Hao S, Hou Z, Lu T, Sun M, et al. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood–brain barrier after traumatic brain injury in mice. Neuroscience. 2015;291:26–36. https://doi.org/10.1016/j.neuroscience.2015.01.070.CrossRefPubMed

26.

Matos IM, Souza DG, Seabra DG, Freire-Maia L, Teixeira MM. Effects of tachykinin NK1 or PAF receptor blockade on the lung injury induced by scorpion venom in rats. Eur. J. Pharmacol. 1999;376(3):293–300.CrossRefPubMed

27.

Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, et al. Circulating MMP2 and MMP9 in breast cancer—potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int. J. Cancer. 2006;119(6):1403–11. https://doi.org/10.1002/ijc.21989.CrossRefPubMed

28.

Okada N, Ishida H, Murata N, Hashimoto D, Seyama Y, Kubota S. Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer. Biochem. Biophys. Res. Commun. 2001;288(1):212–6. https://doi.org/10.1006/bbrc.2001.5741.CrossRefPubMed

29.

Coelho FM, Pessini AC, Coelho AM, Pinho VS, Souza DG, Arantes EC, et al. Platelet activating factor receptors drive CXC chemokine production, neutrophil influx and edema formation in the lungs of mice injected with Tityus serrulatus venom. Toxicon. 2007;50(3):420–7. https://doi.org/10.1016/j.toxicon.2007.04.009.CrossRefPubMed

30.

Van Oosterhout AJ, van Ark I, Hofman G, Van Der Linde HJ, Fattah D, Nijkamp FP. Role of interleukin-5 and substance P in development of airway hyperreactivity to histamine in guinea-pigs. Eur. Respir. J. 1996;9(3):493–9.CrossRefPubMed

31.

Sun XC, Li WB, Li SQ, Li QJ, Chen XL, Ai J. Intrathecal injection of Sar9, Met(O2)11-substance P, neurokinin-1 receptor agonist, increases nitric oxide synthase expression and nitric oxide production in the rat spinal cord. Acta Physiol. Sin. 2003;55(6):677–83.

32.

Moreno I, Pichardo S, Jos A, Gomez-Amores L, Mate A, Vazquez CM, et al. Antioxidant enzyme activity and lipid peroxidation in liver and kidney of rats exposed to microcystin-LR administered intraperitoneally. Toxicon. 2005;45(4):395–402. https://doi.org/10.1016/j.toxicon.2004.11.001.CrossRefPubMed

33.

Sampaio SC, Sousa-e-Silva MC, Borelli P, Curi R, Cury Y. Crotalus durissus terrificus snake venom regulates macrophage metabolism and function. J. Leukoc. Biol. 2001;70(4):551–8.PubMed

34.

Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–6.CrossRefPubMed

35.

Ellman GL. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959;82(1):70–7.CrossRefPubMed

36.

Dardiotis E, Karanikas V, Paterakis K, Fountas K, Hadjigeorgiou GM. Traumatic brain injury and inflammation: emerging role of innate and adaptive immunity. In: Agrawal A, editor. Brain injury-pathogenesis, monitoring, recovery and management. Rijeka: InTech; 2012. p. 23–38.

37.

Adi-Bessalem S, Hammoudi-Triki D, Laraba-Djebari F. Scorpion venom interactions with the immune system. In: Gopalakrishnakone P, editor. Toxinology: scorpion venoms. Dordrecht: Springer; 2013. p. 1–18. https://doi.org/10.1007/978-94-007-6647-1_3-1.CrossRef

38.

Jin W, Dong C. IL-17 cytokines in immunity and inflammation. Emerg. Microb. Infect. 2013;2(9):e60. https://doi.org/10.1038/emi.2013.58.CrossRef

39.

Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, et al. Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation. Nat. Med. 2007;13(10):1173–5. https://doi.org/10.1038/nm1651.CrossRefPubMedPubMedCentral

40.

de Vries HE, Kuiper J, de Boer AG, Van Berkel TJ, Breimer DD. The blood–brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 1997;49(2):143–55.PubMed

41.

Laraba-Djebari F, Adi-Bessalem S, Hammoudi-Triki D. Scorpion venoms: pathogenesis and biotherapies. In: Gopalakrishnakone P, editor. Toxinology: scorpion venoms. Dordrecht: Springer; 2013. p. 1–21. https://doi.org/10.1007/978-94-007-6647-1_2-1.CrossRef

42.

Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediat. Inflamm. 2013;2013:928315. https://doi.org/10.1155/2013/928315.CrossRef

43.

Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ, et al. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin’s lymphomas. Blood. 1999;94(6):2080–9.PubMed

44.

Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann. Surg. 2004;239(4):553–60.CrossRefPubMedPubMedCentral

45.

Raouraoua-Boukari R, Sami-Merah S, Hammoudi-Triki D, Martin-Eauclaire MF, Laraba-Djebari F. Immunomodulation of the inflammatory response induced by Androctonus australis hector neurotoxins: biomarker interactions. Neuroimmunomodulation. 2012;19(2):103–10. https://doi.org/10.1159/000330241.CrossRefPubMed

46.

Griffin GK, Newton G, Tarrio ML, Bu DX, Maganto-Garcia E, Azcutia V, et al. IL-17 and TNF-alpha sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol. 2012;188(12):6287–99. https://doi.org/10.4049/jimmunol.1200385.CrossRefPubMedPubMedCentral

47.

Koffler M, Raskin P, Womble D, Helderman JH. Immunobiological consequence of regulation of insulin receptor on alloactivated lymphocytes in normal and obese subjects. Diabetes. 1991;40(3):364–70.CrossRefPubMed

48.

Viardot A, Grey ST, Mackay F, Chisholm D. Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology. 2007;148(1):346–53. https://doi.org/10.1210/en.2006-0686.CrossRefPubMed

49.

Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J. Clin. Endocrinol. Metab. 2001;86(7):3257–65. https://doi.org/10.1210/jcem.86.7.7623.PubMedCrossRef

50.

Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J. Clin. Investig. 2005;115(8):2277–86. https://doi.org/10.1172/JCI25385.CrossRefPubMed

51.

Klein D, Schubert T, Horch RE, Jauch KW, Jeschke MG. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann. Surg. 2004;240(2):340–9.CrossRefPubMedPubMedCentral

52.

Jeschke MG, Rensing H, Klein D, Schubert T, Mautes AE, Bolder U, et al. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J. Hepatol. 2005;42(6):870–9. https://doi.org/10.1016/j.jhep.2004.12.036.CrossRefPubMed

53.

Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, et al. Immunologic privilege in the central nervous system and the blood–brain barrier. J. Cereb. Blood Flow Metab. 2013;33(1):13–21. https://doi.org/10.1038/jcbfm.2012.153.CrossRefPubMed

54.

Petricevich VL. Scorpion venom and the inflammatory response. Mediat. Inflamm. 2010;2010:903295. https://doi.org/10.1155/2010/903295.CrossRef

55.

Bailey SL, Carpentier PA, McMahon EJ, Begolka WS, Miller SD. Innate and adaptive immune responses of the central nervous system. Crit. Rev. Immunol. 2006;26(2):149–88.CrossRefPubMed

56.

Imhof BA, Engelhardt B, Vadas M. Novel mechanisms of the transendothelial migration of leukocytes. Trends Immunol. 2001;22(8):411–4.CrossRefPubMed

57.

Man S, Ubogu EE, Ransohoff RM. Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol. 2007;17(2):243–50. https://doi.org/10.1111/j.1750-3639.2007.00067.x.CrossRefPubMed

58.

Nguyen HX, O’Barr TJ, Anderson AJ. Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha. J. Neurochem. 2007;102(3):900–12. https://doi.org/10.1111/j.1471-4159.2007.04643.x.CrossRefPubMed

59.

Li H, Liang J, Castrillon DH, DePinho RA, Olson EN, Liu ZP. FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription. Mol. Cell. Biol. 2007;27(7):2676–86. https://doi.org/10.1128/MCB.01748-06.CrossRefPubMedPubMedCentral

60.

Kothari P, Pestana R, Mesraoua R, Elchaki R, Khan KM, Dannenberg AJ, et al. IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages. J Immunol. 2014;192(1):349–57. https://doi.org/10.4049/jimmunol.1301906.CrossRefPubMed

61.

Moretti R, Pansiot J, Bettati D, Strazielle N, Ghersi-Egea JF, Damante G, et al. Blood–brain barrier dysfunction in disorders of the developing brain. Front. Neurosci. 2015;9:40. https://doi.org/10.3389/fnins.2015.00040.CrossRefPubMedPubMedCentral

62.

Cai Y, Liu X, Chen W, Wang Z, Xu G, Zeng Y, et al. TGF-beta1 prevents blood–brain barrier damage and hemorrhagic transformation after thrombolysis in rats. Exp. Neurol. 2015;266:120–6. https://doi.org/10.1016/j.expneurol.2015.02.013.CrossRefPubMed

63.

Kanashiro A, Talbot J, Peres RS, Pinto LG, Bassi GS, Cunha TM, et al. Neutrophil recruitment and articular hyperalgesia in antigen-induced arthritis are modulated by the cholinergic anti-inflammatory pathway. Basic Clin. Pharmacol. Toxicol. 2016;119(5):453–7. https://doi.org/10.1111/bcpt.12611.CrossRefPubMed

64.

Tracey KJ. The inflammatory reflex. Nature. 2002;420(6917):853–9. https://doi.org/10.1038/nature01321.CrossRefPubMed

65.

Chavan SS, Pavlov VA, Tracey KJ. Mechanisms and therapeutic relevance of neuro-immune communication. Immunity. 2017;46(6):927–42. https://doi.org/10.1016/j.immuni.2017.06.008.CrossRefPubMedPubMedCentral

66.

Dianzani C, Collino M, Lombardi G, Garbarino G, Fantozzi R. Substance P increases neutrophil adhesion to human umbilical vein endothelial cells. Br. J. Pharmacol. 2003;139(6):1103–10. https://doi.org/10.1038/sj.bjp.0705344.CrossRefPubMedPubMedCentral

67.

Khorchid A, Fragoso G, Shore G, Almazan G. Catecholamine-induced oligodendrocyte cell death in culture is developmentally regulated and involves free radical generation and differential activation of caspase-3. Glia. 2002;40(3):283–99. https://doi.org/10.1002/glia.10123.CrossRefPubMed

68.

Dousset E, Carrega L, Steinberg JG, Clot-Faybesse O, Jouirou B, Sauze N, et al. Evidence that free radical generation occurs during scorpion envenomation. Comp. Biochem. Physiol. Toxicol. Pharmacol. CBP. 2005;140(2):221–6. https://doi.org/10.1016/j.cca.2005.02.003.CrossRef

69.

Fatani AJ, Furman BL, Zeitlin IJ. The involvement of plasma kinins in the cardiovascular effects of Leiurus quinquestriatus scorpion venom in anaesthetised rabbits. Toxicon. 1998;36(3):523–36.CrossRefPubMed

70.

Fukuhara YD, Dellalibera-Joviliano R, Cunha FQ, Reis ML, Donadi EA. The kinin system in the envenomation caused by the Tityus serrulatus scorpion sting. Toxicol. Appl. Pharmacol. 2004;196(3):390–5. https://doi.org/10.1016/j.taap.2003.12.026.CrossRefPubMed

71.

Mielke JG, Taghibiglou C, Wang YT. Endogenous insulin signaling protects cultured neurons from oxygen-glucose deprivation-induced cell death. Neuroscience. 2006;143(1):165–73. https://doi.org/10.1016/j.neuroscience.2006.07.055.CrossRefPubMed

72.

Blazquez E, Velazquez E, Hurtado-Carneiro V, Ruiz-Albusac JM. Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and Alzheimer’s disease. Front. Endocrinol. 2014;5:161. https://doi.org/10.3389/fendo.2014.00161.CrossRef

73.

Mamik MK, Asahchop EL, Chan WF, Zhu Y, Branton WG, McKenzie BA, et al. Insulin treatment prevents neuroinflammation and neuronal injury with restored neurobehavioral function in models of HIV/AIDS neurodegeneration. J. Neurosci. 2016;36(41):10683–95. https://doi.org/10.1523/JNEUROSCI.1287-16.2016.CrossRefPubMed

Title: Evaluation of neuroprotective effects of insulin on immuno-inflammatory and systemic disorders induced by kaliotoxin, a Kv1.3 channel blocker
Authors: Zahida Taibi-Djennah
Marie-France Martin-Eauclaire
Fatima Laraba-Djebari
Publication date: 01-10-2018
Publisher: Springer International Publishing
Published in: Inflammation Research / Issue 10/2018
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI: https://doi.org/10.1007/s00011-018-1177-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 10/2018

Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function

Reduced intestinal epithelial mitochondrial function enhances in vitro interleukin-8 production in response to commensal Escherichia coli

Lysosomal membrane permeabilization causes secretion of IL-1β in human vascular smooth muscle cells

Fascin protein stabilization by miR-146a implicated in the process of a chronic inflammation-related colon carcinogenesis model

Micronized palmitoylethanolamide reduces joint pain and glial cell activation

Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials